Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)
Conditions
Interventions
- BIOLOGICAL: Certolizumab pegol
- BIOLOGICAL: Certolizumab pegol
- BIOLOGICAL: Certolizumab pegol
Sponsor
UCB Pharma